rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Edward Borkowski

Director

Company insider

Files Form 4 as: Director, GridAI Technologies; EVP, Operations, TherapeuticsMD; EVP & Interim CFO, MiMedx Group; Chief Financial Officer, Aceto; Chief Financial Officer, CareFusion; Chief Financial Officer, Mylan.

In numbers

Trades disclosed
84
Buys
2
Sells
2
Bought
$145K
Sold
$1.8M
Companies
6
Companies where not an officer
1
First trade
9 Feb 2006
Last trade
1 Jan 2026
Last filed
8 Jan 2026

Companies traded

Where they are an officer
TXMD TherapeuticsMDOfficer · Biotechnology · last 1 Jul 20210 buys · 1 sell
MDXG MiMedx GroupOfficer · Medical Devices · last 21 Feb 20190 buys · 0 sells
AcetoOfficer · last 21 Feb 20180 buys · 0 sells
CareFusionOfficer · last 15 Sep 20100 buys · 0 sells
MylanOfficer · last 18 Mar 20092 buys · 1 sell
Everywhere else they filed: board seats, 10% stakes, other companies
GRDX GridAI TechnologiesDirector · Electric Utilities & IPPs · last 1 Jan 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Jan 2026filed 8 Jan 2026GRDX GridAI TechnologiesElectric Utilities & IPPsSEC FORM 4 Code A—40,000 at $0.00filing
1 Jan 2026filed 8 Jan 2026GRDX GridAI TechnologiesElectric Utilities & IPPsSEC FORM 4 Code A—40,000 at $0.00filing
2 Jan 2024filed 4 Jan 2024GRDX GridAI TechnologiesElectric Utilities & IPPsSEC FORM 4 Code A—19,633 at $0.00filing
3 Jan 2023filed 5 Jan 2023GRDX GridAI TechnologiesElectric Utilities & IPPsSEC FORM 4 Code A—84,745 at $0.00filing
3 Jan 2022filed 3 Jan 2022GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—34,482 at $0.00filing
1 Jul 2021filed 2 Jul 2021TXMD TherapeuticsMDoption or derivative · BiotechnologySEC FORM 4 Code A—373,333 at $0.00filing
1 Jul 2021filed 2 Jul 2021TXMD TherapeuticsMDoption or derivative · BiotechnologySEC FORM 4 Code A—186,667 at $0.00filing
11 May 2021filed 12 May 2021TXMD TherapeuticsMDBiotechnologySEC FORM 4 Sold$46K44,252 at $1.04filing
10 May 2021filed 12 May 2021TXMD TherapeuticsMDBiotechnologySEC FORM 4 Code M—103,500filing
10 May 2021filed 12 May 2021TXMD TherapeuticsMDoption or derivative · BiotechnologySEC FORM 4 Code M—103,500 at $0.00filing
4 Jan 2021filed 6 Jan 2021GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—41,237 at $0.00filing
16 Jul 2020filed 20 Jul 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—46.12filing
16 Jul 2020filed 20 Jul 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—230,602filing
16 Jul 2020filed 20 Jul 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—25,774filing
16 Jul 2020filed 20 Jul 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code D—100,000filing
1 Jun 2020filed 1 Jun 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code D—filing
1 Jun 2020filed 1 Jun 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—filing
6 Apr 2020filed 7 Apr 2020GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPsSEC FORM 4 Code A—80,000filing
10 Mar 2020filed 13 Mar 2020GRDX GridAI TechnologiesElectric Utilities & IPPsSEC FORM 4 Code A$8,75014,584 at $0.60filing
10 Mar 2020filed 13 Mar 2020GRDX GridAI TechnologiesElectric Utilities & IPPsSEC FORM 4 Code A$8,7518,414 at $1.04filing

News

TherapeuticsMD (NASDAQ:TXMD) vs. Addex Therapeutics (NASDAQ:ADXN) Head to Head ComparisonTXMD · tickerreport.com · 14 Oct 2026

0 headlines in the last 90 days name Edward Borkowski; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1
Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Rice DougChief Financial Officer · Chief Financial Officer at Mimedx Group, filing Form 4 there in the last year
Kimberly Maersk-MollerChief Commercial Officer · Chief Commercial Officer at Mimedx Group, filing Form 4 there in the last year
Dorothy E. PuhyDirector · Director at Mimedx Group, filing Form 4 there in the last year
Tiffany OlsonDirector · Director at Mimedx Group, filing Form 4 there in the last year
Todd NewtonDirector · Director at Mimedx Group, filing Form 4 there in the last year